Press Releases

Debiopharm announces marketing and supply agreement for Trelstar® in Canada

Debiopharm and NanoCarrier form Research Collaboration on a new platinum compound using the Medicelle TM technology

Debiopharm S.A. invests in NanoCarrier Mezzanine Funding Round

Debiopharm announces import approval from Elplat® (Oxaliplatin) in Japan

Debiopharm S.A. announces the purchase of all outstanding shares of H3 Pharma

Debiopharm S.A. announces marketing approval for a new formulation of Eloxatin® (Oxaliplatin for injection)

H3 Pharma receives approvable letter from FDA for Sanvar® for esophageal variceal bleeding

Debiopharm S.A. and Rowfarma S. de R.L. de C.V. enter into an Exclusive Licensing Agreement in Mexico for two approved…

Debiopharm S.A. and GPC Biotech AG Announce Partnering of Small Molecule MHC Class II Antagonists Program for Autoimune Diseases